Litcius/Paper detail

Rivaroxaban improves survival and decompensation in cirrhotic patients with moderate liver dysfunction. Double-blind, placebo-controlled trial

Ángela Puente Sánchez, Fanny Turón, Javier Martínez, José Ignacio Fortea, Manuel Hernández‐Guerra, Edilmar Alvarado‐Tápias, Mònica Pons, Marta Magaz, Elba Llop, Carmen Álvarez‐Navascués, José Castellote, Marina Berenguer, Helena Masnou, Rafael Bañares, Marta Casado, Javier Ampuero, Georgina Casanovas, Carlos Redondo, Patrícia Huelin, Luís Téllez, Dalia Morales Arráez, Manuel Rodríguez, Victoria Aguilera, Anna Baiges, Virginia Hernández–Gea, Christie Perelló, José Luis Calleja Panero, Joan Genescà, Càndid Villanueva, Carlos González‐Alayón, Agustı́n Albillos, Javier Crespo, Juan Carlos García‐Pagán

2023Journal of Hepatology24 citationsDOI

Topics & Concepts

MedicineRivaroxabanDecompensationPlaceboDouble blindInternal medicineLiver dysfunctionCirrhosisGastroenterologyAtrial fibrillationPathologyWarfarinAlternative medicineLiver Disease and TransplantationLiver Disease Diagnosis and TreatmentDrug-Induced Hepatotoxicity and Protection